<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Lipids Health Dis</journal-id><journal-id journal-id-type="iso-abbrev">Lipids Health Dis</journal-id><journal-title-group><journal-title>Lipids in Health and Disease</journal-title></journal-title-group><issn pub-type="epub">1476-511X</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29216922</article-id><article-id pub-id-type="pmc">5721610</article-id><article-id pub-id-type="publisher-id">631</article-id><article-id pub-id-type="doi">10.1186/s12944-017-0631-2</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Lactic-fermented egg white improves visceral fat obesity in Japanese subjects&#x02014;double-blind, placebo-controlled study</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Matsuoka</surname><given-names>Ryosuke</given-names></name><address><email>ryosuke_matsuoka@kewpie.co.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Kamachi</surname><given-names>Keiko</given-names></name><address><email>kamachi@eiyo.ac.jp</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Usuda</surname><given-names>Mika</given-names></name><address><email>mika_usuda@kewpie.co.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Wei</given-names></name><address><email>yui_ou@kewpie.co.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Masuda</surname><given-names>Yasunobu</given-names></name><address><email>yasunobu_masuda@kewpie.co.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Kunou</surname><given-names>Masaaki</given-names></name><address><email>masaaki_kunou@kewpie.co.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Tanaka</surname><given-names>Akira</given-names></name><address><email>atanaka@eiyo.ac.jp</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Utsunomiya</surname><given-names>Kazunori</given-names></name><address><email>kazu-utsunomiya@jikei.ac.jp</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label>R&#x00026;D Division, Kewpie Corporation, 2-5-7 Sengawa Kewport, Sengawa-Cho, Chofu-Shi, Tokyo, 182-0002 Japan </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0370 2825</institution-id><institution-id institution-id-type="GRID">grid.411981.4</institution-id><institution>Nutrition Clinic, </institution><institution>Kagawa Nutrition University, </institution></institution-wrap>3-24-3, Komagome, Toshima-ku, Tokyo, 170-8481 Japan </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0661 2073</institution-id><institution-id institution-id-type="GRID">grid.411898.d</institution-id><institution>Department of Internal Medicine, </institution><institution>The Jikei University School of Medicine, </institution></institution-wrap>3-25-8, Nishi-shinbashi, Minato-ku, Tokyo, 105-8461 Japan </aff></contrib-group><pub-date pub-type="epub"><day>8</day><month>12</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>8</day><month>12</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>16</volume><elocation-id>237</elocation-id><history><date date-type="received"><day>27</day><month>6</month><year>2017</year></date><date date-type="accepted"><day>29</day><month>11</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">It was reported that egg white protein (EWP) reduced body fat in rats. We developed a lactic-fermented egg white (LE) that facilitates the consumption of egg whites by fermenting them with lactobacillus, and were able to study their intake in humans. In this double-blind, placebo-controlled design, we evaluated the effect of LE on visceral fat area (VFA).</p></sec><sec><title>Methods</title><p id="Par2">Participants included 37 adult males and females aged &#x02265;40&#x000a0;years (VFA at navel &#x02265;100&#x000a0;cm<sup>2</sup>). They were divided into two groups: the control group and the LE group. The control and LE groups consumed drinks containing whey and LE, respectively, for 12&#x000a0;weeks (providing 8&#x000a0;g protein/day). VFA was measured at baseline and at week 12 of intake. Abdominal girth was measured at baseline and at weeks 6 and 12.</p></sec><sec><title>Results</title><p id="Par3">LE intake decreased VFA significantly compared with baseline (&#x02212;8.89&#x000a0;cm<sup>2</sup>, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05), and VFA was significantly lower than that in the control group (+1.71&#x000a0;cm<sup>2</sup>, p&#x02009;&#x0003c;&#x02009;0.05). The LE group showed significant improvement in the ratio of visceral to subcutaneous fat area compared with baseline and the control group (p&#x02009;&#x0003c;&#x02009;0.05).</p></sec><sec><title>Conclusions</title><p id="Par4">The results demonstrated that LE reduces VFA and improves the ratio of visceral to subcutaneous fat area. As other measurement items were not influenced, we concluded that LE improves visceral fat obesity.</p></sec><sec><title>Trial registration</title><p id="Par5">This clinical trial was retrospectively registered with the University hospital Medical Information Network (UMIN) Center, (<ext-link ext-link-type="uri" xlink:href="https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000030810">UMIN000026949</ext-link>; registered on 11/04/2017; <ext-link ext-link-type="uri" xlink:href="http://www.umin.ac.jp">http://www.umin.ac.jp</ext-link>/).</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Egg white</kwd><kwd>Visceral fat</kwd><kwd>Obesity</kwd><kwd>Japanese</kwd><kwd>Protein</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par11">Visceral fat obesity causes complications such as dyslipidaemia, abnormal glucose tolerance, and hypertension. Along with serum LDL-cholesterol concentration, it is a risk factor for arteriosclerotic disease [<xref ref-type="bibr" rid="CR1">1</xref>]. In Japan, approximately 50% men and 20% women &#x02265;40&#x000a0;years have metabolic syndrome or pre-metabolic syndrome, which is becoming more serious [<xref ref-type="bibr" rid="CR2">2</xref>].</p><p id="Par12">Hen eggs contain almost all essential nutrients (except vitamin C and dietary fiber), and are known to be of high nutritive value [<xref ref-type="bibr" rid="CR3">3</xref>]. Attention has been drawn to the cholesterol contained in eggs, and nutritional education for dyslipidaemia recommends avoiding egg consumption. Although the cholesterol in eggs is found in the yolk, some reports have indicated that consumption of egg yolk does not increase blood cholesterol levels [<xref ref-type="bibr" rid="CR4">4</xref>&#x02013;<xref ref-type="bibr" rid="CR6">6</xref>] or mortality due to coronary heart disease [<xref ref-type="bibr" rid="CR7">7</xref>]. Therefore, we considered whether the constituent that improves lipid metabolism is contained in eggs, specifically egg white protein (EWP). EWP is high in protein and low in fat and has been reported to reduce serum total and LDL cholesterol levels [<xref ref-type="bibr" rid="CR8">8</xref>&#x02013;<xref ref-type="bibr" rid="CR10">10</xref>].</p><p id="Par13">EWP is said to lower blood cholesterol by inhibiting cholesterol absorption in the small intestines. However, in doing so, triglyceride absorption is also inhibited [<xref ref-type="bibr" rid="CR11">11</xref>]. Therefore, EWP not only reduces serum LDL cholesterol level but is also believed to prevent arteriosclerotic disease by reducing visceral fat.</p><p id="Par14">In an experiment on rats, Matsuoka et al. reported that egg white proteins could reduce body and abdominal fat [<xref ref-type="bibr" rid="CR12">12</xref>]. However, it is unclear whether the reduction was effective in human.</p><p id="Par15">The consumption of egg white itself poses a problem in terms of taste and physical properties. We therefore developed a lactic-fermented egg white (LE) that facilitates the consumption of egg whites by fermenting them with lactobacillus, and were able to study their intake in humans [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. In a previous study, it was reported that the EWPs ovalbumin and ovotransferrin could inhibit lipid absorption [<xref ref-type="bibr" rid="CR11">11</xref>]. It has been reported that beta-conglycinin, a soy protein, reduced visceral fat at the speed of 5&#x000a0;g/day [<xref ref-type="bibr" rid="CR15">15</xref>]. Ovalbumin and ovotransferrin are reported to contain 54% and 11% EWP, respectively [<xref ref-type="bibr" rid="CR16">16</xref>]. If we suppose that ovalbumin and ovotransferrin have the same visceral fat-reducing effect as beta-conglycinin at a daily intake of 5&#x000a0;g, a daily intake of 8&#x000a0;g of EWP would be required. We therefore conducted a double-blind, placebo-controlled study to evaluate the visceral fat-reducing effect of protein in Japanese adults with visceral fat obesity, via daily intake of LE for 12&#x000a0;weeks.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Test foods</title><p id="Par16">The control drink and the drink containing LE were prepared by Co-op Foods Co., Ltd. (Tokyo, Japan). Flavors, sweeteners and water were added to the whey (Nippon-Shinyaku Co., Ltd., Kyoto, Japan) and LE [<xref ref-type="bibr" rid="CR13">13</xref>] (Kewpie Egg Corporation, Tokyo, Japan) of each drink. Once homogeneously dispersed, the preparation was heat-sterilized. Measurement using the Kjeldahl method [<xref ref-type="bibr" rid="CR17">17</xref>] indicated that both drinks contained 8&#x000a0;g of protein per 180&#x000a0;g serving. Ovalbumin content in LE was assessed by the sandwich ELISA procedure using anti-chicken ovalbumin polyclonal antibody, and horseradish peroxidase-labeled anti-chicken ovalbumin polyclonal antibody, respectively. A commercial kit, Egg (Ovalbumin) ELISA kit II (Morinaga Institute of Biological Science Inc., Yokohama, Japan) was used with absorbance detected at 450&#x000a0;nm by a multi-detection microplate reader (Powerscan&#x000ae; HT, DS Pharma Biomedical Co. Ltd., Osaka, Japan). Ovalbumin content of the LE drink was 4.17&#x000a0;g/180&#x000a0;g, as measured via sandwich ELISA. Based on a previous report that ovotransferrin accounts for 11% of total EWP [<xref ref-type="bibr" rid="CR17">17</xref>], the content of ovotransferrin was calculated to be 0.88&#x000a0;g/180&#x000a0;g LE (Calculated value).</p></sec><sec id="Sec4"><title>Participants and test methods</title><p id="Par17">Recruitment was done per the following process: Japanese subjects with body mass index (BMI) (&#x02265;25), aged more than 40&#x000a0;years (male) or postmenopausal female, who were not undergoing treatment for hyperlipidemia or diabetes, who had no subjective symptoms of gout and who were capable of filling out the required forms, such as self-diagnosis forms, and of visiting a designated institution as scheduled. The exclusion criteria were as follows: taking drugs that could potentially affect the test results (e.g., anti-hyperlipidemic agents, anti-diabetic agents, oral corticosteroid formulations, and antihypertensive agents); regular consumption of foods for specified health uses that could potentially affect test results; excessive alcohol consumption; suspected allergic reactions (particularly to egg and milk); participation in other clinical studies; a history of serious liver damage, kidney damage, or myocardial infarction; a history of, or current, hepatitis; and serious anemia. In this study, 80 adults were screened and 48 individuals with visceral fat area (VFA) (&#x02265;100&#x000a0;cm<sup>2</sup>) were included as test subjects.</p><p id="Par18">The study followed a double-blind, parallel-arm design. Participants were divided into two groups: a control group and LE group. The control group was given a drink containing whey (8&#x000a0;g of protein), and the LE group was given a drink containing LE (8&#x000a0;g of protein) every day at breakfast for 12 continuous weeks.</p><p id="Par19">At 0 and 12&#x000a0;weeks of intake, computed tomographic (CT) scanning of the abdomen (Aquilion&#x02122;, Toshiba Medical Systems Corporation, Tochigi, Japan) was performed, and VFA was measured at the navel (Fat Scan, East Japan Institute of Technology Co., Ltd., Ibaraki, Japan). CT scans were conducted at the Nakajima Clinic (Tokyo, Japan). At weeks 0, 6, and 12, bodyweight, blood pressure, and abdominal girth, respectively, were measured after fasting overnight. Blood was sampled from a forearm vein, and blood tests were performed at baseline, and weeks 6 and 12 of intake.</p></sec><sec id="Sec5"><title>Blood tests</title><p id="Par20">Peripheral blood test was performed using flow cytometry. Serum analysis included the following items: total cholesterol (enzyme method); HDL cholesterol (direct method); triglyceride (enzyme method); free fatty acid (FFA; enzyme method); phospholipid (enzyme method); glucose (hexokinase UV test); HbA1c (latex coagulating method); RLP cholesterol (immunoadsorption); insulin (CLEIA method); AST (JSCC transferable method); ALT (JSCC transferable method); gamma-GTP (JSCC transferable method); blood urea nitrogen (BUN; urease LED UV method); creatinine (enzyme method); and uric acid (enzyme method). LDL cholesterol concentration was calculated using the Friedewald formula [<xref ref-type="bibr" rid="CR18">18</xref>]. Blood tests were performed by SRL Corporation (Tokyo, Japan).</p></sec><sec id="Sec6"><title>Dietary intake</title><p id="Par21">The nutritional value of the content of meals recorded by participants over a three-day period was calculated using Excel Eiyoukun Food Frequency Questionnaire version 5 (Kenpakusha, Tokyo, Japan). The 2010 Standard Table of Food Composition in Japan database was used in this nutrition-calculation software.</p></sec><sec id="Sec7"><title>Statistical analysis</title><p id="Par22">Test results are shown as mean&#x02009;&#x000b1;&#x02009;standard error. Comparisons with baseline values were performed using paired <italic>t</italic>-tests for VFA and Dunnett&#x02019;s test for all other items. Comparisons with the control group were performed using the student&#x02019;s <italic>t</italic>-test. A significance level of less than 5% was considered substantial. Statistical analyses were performed using SPSS version 20 (SPSS Inc., Tokyo, Japan). Change in VFA is indicated by &#x02206; cm<sup>2</sup>.</p></sec></sec><sec id="Sec8"><title>Results</title><sec id="Sec9"><title>Adherence and participant attributes</title><p id="Par23">During the study period, two participants withdrew from the study; one individual in the control group could not get accustomed to the taste of the test food and one individual in the LE group experienced melena. The latter&#x02019;s condition was assumed to be due to the participant&#x02019;s tendency toward constipation and the melena was thus determined to not be causally related to the test food (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Participant flow through a randomized trial</p></caption><graphic xlink:href="12944_2017_631_Fig1_HTML" id="MO1"/></fig>
</p><p id="Par24">From the control group, seven participants were excluded: two of whom did not fast prior to blood sampling; four who did not complete the food diary sufficiently to track actual food intake; and one who was inconsistent in the timing of test food consumption. From the LE group, two participants were excluded: one who did not fast prior to blood sampling and one who completed the food diary insufficiently (Fig.<xref rid="Fig1" ref-type="fig">1</xref>). From the above, we analyzed 18 individuals in the control group and 19 in the LE group. There were no significant differences observed at baseline between the two groups in terms of age, height, or BMI (<italic>p</italic>&#x02009;&#x0003e;&#x02009;0.05, Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Background of subjects</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th colspan="3">Control</th><th colspan="3">LE</th></tr></thead><tbody><tr><td>Age (y)</td><td>55.2</td><td>&#x000b1;</td><td>1.5</td><td>56.6</td><td>&#x000b1;</td><td>1.2</td></tr><tr><td>Height (cm)</td><td>166</td><td>&#x000b1;</td><td>3</td><td>167</td><td>&#x000b1;</td><td>2</td></tr><tr><td>Body weight (kg)</td><td>76.1</td><td>&#x000b1;</td><td>2.5</td><td>78.4</td><td>&#x000b1;</td><td>2.2</td></tr><tr><td>BMI</td><td>27.5</td><td>&#x000b1;</td><td>0.7</td><td>28.0</td><td>&#x000b1;</td><td>0.7</td></tr><tr><td>Systolic blood presure (mmHg)</td><td>131</td><td>&#x000b1;</td><td>5</td><td>135</td><td>&#x000b1;</td><td>4</td></tr><tr><td>Diastolic blood pressure (mmHg)</td><td>80.1</td><td>&#x000b1;</td><td>3.1</td><td>87.1</td><td>&#x000b1;</td><td>2.5</td></tr></tbody></table><table-wrap-foot><p>Mean&#x02009;&#x000b1;&#x02009;SE of 18 (control) and 19 (LE)</p><p>
<italic>Control</italic> Control group, <italic>LE</italic> Lactic fermented egg white group</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec10"><title>Dietary intake</title><p id="Par25">There was no significant change in the amount of food consumed during the study period in either group (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Dietary intake of subjects</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th/><th colspan="9">Intake Period (Weeks)</th></tr><tr><th/><th/><th colspan="3">0</th><th colspan="3">6</th><th colspan="3">12</th></tr></thead><tbody><tr><td>Energy (kcal)</td><td>Control</td><td>1956</td><td>&#x000b1;</td><td>109</td><td>2073</td><td>&#x000b1;</td><td>163</td><td>1976</td><td>&#x000b1;</td><td>112</td></tr><tr><td/><td>LE</td><td>2163</td><td>&#x000b1;</td><td>175</td><td>1978</td><td>&#x000b1;</td><td>93</td><td>2012</td><td>&#x000b1;</td><td>77</td></tr><tr><td>Protein (g)</td><td>Control</td><td>71.9</td><td>&#x000b1;</td><td>5.3</td><td>75.1</td><td>&#x000b1;</td><td>5.2</td><td>73.4</td><td>&#x000b1;</td><td>5.0</td></tr><tr><td/><td>LE</td><td>80.1</td><td>&#x000b1;</td><td>6.9</td><td>73.0</td><td>&#x000b1;</td><td>3.3</td><td>74.2</td><td>&#x000b1;</td><td>3.3</td></tr><tr><td>Lipids (g)</td><td>Control</td><td>64.9</td><td>&#x000b1;</td><td>4.9</td><td>68.6</td><td>&#x000b1;</td><td>7.2</td><td>68.0</td><td>&#x000b1;</td><td>4.6</td></tr><tr><td/><td>LE</td><td>68.7</td><td>&#x000b1;</td><td>8.5</td><td>61.0</td><td>&#x000b1;</td><td>4.2</td><td>66.8</td><td>&#x000b1;</td><td>5.2</td></tr><tr><td>Carbohydrate (g)</td><td>Control</td><td>251</td><td>&#x000b1;</td><td>15</td><td>266</td><td>&#x000b1;</td><td>21</td><td>250</td><td>&#x000b1;</td><td>15</td></tr><tr><td/><td>LE</td><td>276</td><td>&#x000b1;</td><td>20</td><td>244</td><td>&#x000b1;</td><td>13</td><td>251</td><td>&#x000b1;</td><td>11</td></tr><tr><td>Cholesterol (mg)</td><td>Control</td><td>388</td><td>&#x000b1;</td><td>47</td><td>396</td><td>&#x000b1;</td><td>42</td><td>391</td><td>&#x000b1;</td><td>37</td></tr><tr><td/><td>LE</td><td>330</td><td>&#x000b1;</td><td>33</td><td>335</td><td>&#x000b1;</td><td>27</td><td>351</td><td>&#x000b1;</td><td>36</td></tr><tr><td>Dietary fiber (g)</td><td>Control</td><td>11.5</td><td>&#x000b1;</td><td>0.9</td><td>12.4</td><td>&#x000b1;</td><td>1.1</td><td>11.8</td><td>&#x000b1;</td><td>0.9</td></tr><tr><td/><td>LE</td><td>13.6</td><td>&#x000b1;</td><td>1.3</td><td>12.1</td><td>&#x000b1;</td><td>1.3</td><td>12.7</td><td>&#x000b1;</td><td>0.8</td></tr></tbody></table><table-wrap-foot><p>Mean&#x02009;&#x000b1;&#x02009;SE of 18 (control) and 19 (LE)</p><p>
<italic>Control</italic> Control group, <italic>LE</italic> Lactic fermented egg white group</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec11"><title>Physical condition</title><p id="Par26">The abdominal girth of the control group was significantly lower at 12&#x000a0;weeks than at baseline. No significant difference was observed for any other items between the control and LE groups, nor compared to baseline (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>).<table-wrap id="Tab3"><label>Table 3</label><caption><p>Results of body composition at the navel level</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th/><th colspan="6">Intake Periods (Weeks)</th></tr><tr><th/><th/><th colspan="3">0</th><th colspan="3">12</th></tr></thead><tbody><tr><td rowspan="2">Body weight (kg)</td><td>Control</td><td>76.1</td><td>&#x000b1;</td><td>2.5</td><td>76.0</td><td>&#x000b1;</td><td>2.5</td></tr><tr><td>LE</td><td>78.4</td><td>&#x000b1;</td><td>2.2</td><td>78.5</td><td>&#x000b1;</td><td>2.2</td></tr><tr><td rowspan="2">BMI</td><td>Control</td><td>27.5</td><td>&#x000b1;</td><td>0.7</td><td>27.4</td><td>&#x000b1;</td><td>0.7</td></tr><tr><td>LE</td><td>28.0</td><td>&#x000b1;</td><td>0.7</td><td>28.1</td><td>&#x000b1;</td><td>0.7</td></tr><tr><td rowspan="2">Waist (cm)</td><td>Control</td><td>100</td><td>&#x000b1;</td><td>2</td><td>99.8</td><td>&#x000b1;</td><td>2.0<sup>a</sup>
</td></tr><tr><td>LE</td><td>99.3</td><td>&#x000b1;</td><td>1.9</td><td>98.4</td><td>&#x000b1;</td><td>2.2</td></tr><tr><td rowspan="2">Total fat area (cm<sup>2</sup>)</td><td>Control</td><td>391</td><td>&#x000b1;</td><td>22</td><td>391</td><td>&#x000b1;</td><td>27</td></tr><tr><td>LE</td><td>386</td><td>&#x000b1;</td><td>27</td><td>390</td><td>&#x000b1;</td><td>28</td></tr><tr><td rowspan="2">Subcutaneous fat area (cm<sup>2</sup>)</td><td>Control</td><td>249</td><td>&#x000b1;</td><td>20</td><td>246</td><td>&#x000b1;</td><td>24</td></tr><tr><td>LE</td><td>240</td><td>&#x000b1;</td><td>24</td><td>254</td><td>&#x000b1;</td><td>23<sup>a</sup>
</td></tr><tr><td rowspan="2">Visceral fat area (cm<sup>2</sup>)</td><td>Control</td><td>143</td><td>&#x000b1;</td><td>7</td><td>144</td><td>&#x000b1;</td><td>8</td></tr><tr><td>LE</td><td>145</td><td>&#x000b1;</td><td>9</td><td>136</td><td>&#x000b1;</td><td>9<sup>a</sup>
</td></tr><tr><td rowspan="2">Visceral/Subcutaneous</td><td>Control</td><td>0.766</td><td>&#x000b1;</td><td>0.078</td><td>0.597</td><td>&#x000b1;</td><td>0.052</td></tr><tr><td>LE</td><td>0.656</td><td>&#x000b1;</td><td>0.048</td><td>0.546</td><td>&#x000b1;</td><td>0.041*</td></tr></tbody></table><table-wrap-foot><p>Mean&#x02009;&#x000b1;&#x02009;SE of 18 (control) and 19 (LE)</p><p>
<sup>a</sup>p&#x02009;&#x0003c;&#x02009;0.05 vs. 0&#x000a0;weeks by paired t-test</p><p>
<italic>Control</italic> Control group, <italic>LE</italic> Lactic fermented egg white group</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec12"><title>Fat area at the navel</title><p id="Par27">There was no significant difference in the total fat area in the LE group compared to baseline or the control group (Table <xref rid="Tab3" ref-type="table">3</xref>). Although no significant difference was observed between the two groups in terms of VFA and subcutaneous fat area, the LE group showed significantly less VFA, and a significant increase in subcutaneous fat area compared to baseline (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05). The control group showed no significant difference compared to baseline (Table <xref rid="Tab3" ref-type="table">3</xref>).</p><p id="Par28">Calculation of the visceral to subcutaneous fat ratio indicated a significantly lower ratio in the LE group compared to baseline. There was no significant difference in the control group compared to baseline or between the two groups (Table <xref rid="Tab3" ref-type="table">3</xref>).</p><p id="Par29">Calculation of the change in VFA revealed a significant reduction in the LE group compared to both baseline and the control group. With regards to the change in visceral to subcutaneous fat ratio at the navel (&#x02206;), the value was significantly reduced by the intake of LE compared to the control group and baseline ratio (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref> and Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><p>Change in visceral fat area and ratio of visceral to subcutaneous fat area of the subjects fed LE or whey for 12&#x000a0;weeks. &#x00394;: 12&#x000a0;weeks&#x02013;0&#x000a0;weeks. Mean&#x02009;&#x000b1;&#x02009;SE of 18 (control) and 19 (LE), *: <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 vs. 0&#x000a0;weeks by paired <italic>t</italic>-test</p></caption><graphic xlink:href="12944_2017_631_Fig2_HTML" id="MO2"/></fig>
<fig id="Fig3"><label>Fig. 3</label><caption><p>A photographic example of the change in visceral fat area (VFA) of the subjects fed LE for 12&#x000a0;weeks. Red: Visceral fat, Pink: Subcutaneous fat. <bold>a</bold>: Pre-intake (VFA&#x02009;=&#x02009;119&#x000a0;cm<sup>2</sup>), <bold>b</bold>: Post-intake (VFA&#x02009;=&#x02009;102&#x000a0;cm<sup>2</sup>)</p></caption><graphic xlink:href="12944_2017_631_Fig3_HTML" id="MO3"/></fig>
</p></sec><sec id="Sec13"><title>Serum biochemical analysis</title><p id="Par30">There was no significant variation observed in serum total cholesterol, LDL cholesterol, RLP cholesterol, triglycerides, phospholipids, insulin, or blood glucose levels. While the LE group exhibited significantly lower FFA concentrations compared to the control group in week 6 (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05), there was no significant difference observed in week 12. Moreover, while the LE group showed significantly lower HDL-cholesterol levels in week 6 compared to baseline (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05), there was no significant difference observed in week 12 (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>).<table-wrap id="Tab4"><label>Table 4</label><caption><p>Serum biochemical analysis</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th/><th colspan="10">Intake Period (Weeks)</th></tr><tr><th/><th/><th colspan="3">0</th><th colspan="3">6</th><th colspan="3">12</th><th/></tr></thead><tbody><tr><td>Total Cholesterol</td><td>Control</td><td>209</td><td>&#x000b1;</td><td>6</td><td>210</td><td>&#x000b1;</td><td>7</td><td>209</td><td>&#x000b1;</td><td>8</td><td/></tr><tr><td>(mg/dL)</td><td>LE</td><td>215</td><td>&#x000b1;</td><td>6</td><td>210</td><td>&#x000b1;</td><td>6</td><td>217</td><td>&#x000b1;</td><td>6</td><td/></tr><tr><td>HDL-Cholesterol</td><td>Control</td><td>55.8</td><td>&#x000b1;</td><td>2.26</td><td>55.1</td><td>&#x000b1;</td><td>2.60</td><td>54.8</td><td>&#x000b1;</td><td>2.26</td><td/></tr><tr><td>(mg/dL)</td><td>LE</td><td>58.1</td><td>&#x000b1;</td><td>2.85</td><td>52.4</td><td>&#x000b1;</td><td>2.02<sup>a</sup>
</td><td>55.8</td><td>&#x000b1;</td><td>2.51</td><td/></tr><tr><td>LDL-Cholesterol</td><td>Control</td><td>133</td><td>&#x000b1;</td><td>4</td><td>131</td><td>&#x000b1;</td><td>5</td><td>131</td><td>&#x000b1;</td><td>6</td><td/></tr><tr><td>(mg/dL)</td><td>LE</td><td>132</td><td>&#x000b1;</td><td>5</td><td>130</td><td>&#x000b1;</td><td>6</td><td>135</td><td>&#x000b1;</td><td>5</td><td/></tr><tr><td>Triglyceride</td><td>Control</td><td>127</td><td>&#x000b1;</td><td>16</td><td>150</td><td>&#x000b1;</td><td>25</td><td>123</td><td>&#x000b1;</td><td>15</td><td/></tr><tr><td>(mg/dL)</td><td>LE</td><td>132</td><td>&#x000b1;</td><td>18</td><td>150</td><td>&#x000b1;</td><td>18</td><td>134</td><td>&#x000b1;</td><td>12</td><td/></tr><tr><td>NEFA</td><td>Control</td><td>496</td><td>&#x000b1;</td><td>31</td><td>553</td><td>&#x000b1;</td><td>36</td><td>515</td><td>&#x000b1;</td><td>34</td><td/></tr><tr><td>(mEq/L)</td><td>LE</td><td>481</td><td>&#x000b1;</td><td>42</td><td>443</td><td>&#x000b1;</td><td>37#</td><td>543</td><td>&#x000b1;</td><td>49</td><td/></tr><tr><td>Phospholipid</td><td>Control</td><td>218</td><td>&#x000b1;</td><td>7</td><td>221</td><td>&#x000b1;</td><td>8</td><td>215</td><td>&#x000b1;</td><td>7</td><td/></tr><tr><td>(mg/dL)</td><td>LE</td><td>224</td><td>&#x000b1;</td><td>6</td><td>221</td><td>&#x000b1;</td><td>5</td><td>222</td><td>&#x000b1;</td><td>5</td><td/></tr><tr><td>Glucose</td><td>Control</td><td>92.8</td><td>&#x000b1;</td><td>2.0</td><td>91.7</td><td>&#x000b1;</td><td>2.0</td><td>96.0</td><td>&#x000b1;</td><td>3.0</td><td/></tr><tr><td>(mg/dL)</td><td>LE</td><td>92.7</td><td>&#x000b1;</td><td>1.8</td><td>94.4</td><td>&#x000b1;</td><td>2.1</td><td>93.6</td><td>&#x000b1;</td><td>2.6</td><td/></tr><tr><td>Insulin</td><td>Control</td><td>6.65</td><td>&#x000b1;</td><td>0.98</td><td>7.32</td><td>&#x000b1;</td><td>0.95</td><td>6.93</td><td>&#x000b1;</td><td>0.55</td><td/></tr><tr><td>(mg/mL)</td><td>LE</td><td>6.26</td><td>&#x000b1;</td><td>0.74</td><td>8.35</td><td>&#x000b1;</td><td>1.33</td><td>7.50</td><td>&#x000b1;</td><td>0.82</td><td/></tr><tr><td>HbA1c (NGSP)</td><td>Control</td><td>5.53</td><td>&#x000b1;</td><td>0.09</td><td>5.50</td><td>&#x000b1;</td><td>0.08</td><td>5.51</td><td>&#x000b1;</td><td>0.09</td><td/></tr><tr><td>(%)</td><td>LE</td><td>5.56</td><td>&#x000b1;</td><td>0.08</td><td>5.54</td><td>&#x000b1;</td><td>0.10</td><td>5.56</td><td>&#x000b1;</td><td>0.10</td><td/></tr><tr><td>RLP-Cholsterol</td><td>Control</td><td>4.81</td><td>&#x000b1;</td><td>0.66</td><td>6.25</td><td>&#x000b1;</td><td>1.29</td><td>4.73</td><td>&#x000b1;</td><td>0.49</td><td/></tr><tr><td>(mg/dL)</td><td>LE</td><td>5.58</td><td>&#x000b1;</td><td>0.93</td><td>6.73</td><td>&#x000b1;</td><td>1.21</td><td>5.34</td><td>&#x000b1;</td><td>0.54</td><td/></tr></tbody></table><table-wrap-foot><p>Mean&#x02009;&#x000b1;&#x02009;SE of 18 (control) and 19 (LE)</p><p>
<sup>a</sup>p&#x02009;&#x0003c;&#x02009;0.05 vs. 0&#x000a0;weeks by Dunnett test&#x03001;#p&#x02009;&#x0003c;&#x02009;0.05 vs. Control group by Student&#x02019;s <italic>t</italic>-test</p><p>
<italic>Control</italic> Control group, <italic>LE</italic> Lactic fermented egg white group</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec14"><title>Hematological tests</title><p id="Par31">The control group exhibited significantly high mean corpuscular volume (MCV) in week 6 compared to baseline, whereas mean corpuscular hemoglobin level (MCHC) in weeks 6 and 12 were significantly lower than baseline (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05). The LE group showed significantly higher MCV in week 6 compared to baseline (p&#x02009;&#x0003c;&#x02009;0.05; Table&#x000a0;<xref rid="Tab5" ref-type="table">5</xref>). Throughout the entire study period, MCV and MCHC were significantly lower in the LE group compared to the control group (p&#x02009;&#x0003c;&#x02009;0.05). All items&#x02019; values stayed within the normal range and no particular problems were observed (Table <xref rid="Tab5" ref-type="table">5</xref>).<table-wrap id="Tab5"><label>Table 5</label><caption><p>Results of hematological tests and hepatic and kidney function</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th/><th colspan="9">Intake Period (Weeks)</th></tr><tr><th/><th/><th colspan="3">0</th><th colspan="3">6</th><th colspan="3">12</th></tr></thead><tbody><tr><td>WBC</td><td>Control</td><td>5683</td><td>&#x000b1;</td><td>334</td><td>6072</td><td>&#x000b1;</td><td>382</td><td>5972</td><td>&#x000b1;</td><td>327</td></tr><tr><td>(/&#x003bc;L)</td><td>LE</td><td>5779</td><td>&#x000b1;</td><td>310</td><td>5758</td><td>&#x000b1;</td><td>301</td><td>5579</td><td>&#x000b1;</td><td>290</td></tr><tr><td>RBC</td><td>Control</td><td>473</td><td>&#x000b1;</td><td>10</td><td>470</td><td>&#x000b1;</td><td>9</td><td>476</td><td>&#x000b1;</td><td>10</td></tr><tr><td>(/&#x003bc;L)</td><td>LE</td><td>488</td><td>&#x000b1;</td><td>11</td><td>480</td><td>&#x000b1;</td><td>10</td><td>491</td><td>&#x000b1;</td><td>9</td></tr><tr><td>Hb</td><td>Control</td><td>14.7</td><td>&#x000b1;</td><td>0.3</td><td>14.7</td><td>&#x000b1;</td><td>0.3</td><td>14.6</td><td>&#x000b1;</td><td>0.3</td></tr><tr><td>(g/dL)</td><td>LE</td><td>14.8</td><td>&#x000b1;</td><td>0.3</td><td>14.7</td><td>&#x000b1;</td><td>0.3</td><td>14.7</td><td>&#x000b1;</td><td>0.3</td></tr><tr><td>Ht</td><td>Control</td><td>44.4</td><td>&#x000b1;</td><td>0.9</td><td>44.9</td><td>&#x000b1;</td><td>0.8</td><td>44.6</td><td>&#x000b1;</td><td>0.8</td></tr><tr><td>(%)</td><td>LE</td><td>45.0</td><td>&#x000b1;</td><td>0.9</td><td>44.8</td><td>&#x000b1;</td><td>0.8</td><td>45.0</td><td>&#x000b1;</td><td>0.7</td></tr><tr><td>MCV</td><td>Control</td><td>93.9</td><td>&#x000b1;</td><td>0.6</td><td>95.7</td><td>&#x000b1;</td><td>0.8<sup>a</sup>
</td><td>93.9</td><td>&#x000b1;</td><td>0.7</td></tr><tr><td>(fl)</td><td>LE</td><td>92.3</td><td>&#x000b1;</td><td>0.7</td><td>93.5</td><td>&#x000b1;</td><td>0.8<sup>a</sup>
</td><td>91.8</td><td>&#x000b1;</td><td>0.7#</td></tr><tr><td>MCH</td><td>Control</td><td>31.1</td><td>&#x000b1;</td><td>0.3</td><td>31.2</td><td>&#x000b1;</td><td>0.3</td><td>30.8</td><td>&#x000b1;</td><td>0.3</td></tr><tr><td>(pg)</td><td>LE</td><td>30.3</td><td>&#x000b1;</td><td>0.3</td><td>30.6</td><td>&#x000b1;</td><td>0.3<sup>a</sup>
</td><td>30.1</td><td>&#x000b1;</td><td>0.3*</td></tr><tr><td>MCHC</td><td>Control</td><td>33.0</td><td>&#x000b1;</td><td>0.2</td><td>32.6</td><td>&#x000b1;</td><td>0.2<sup>a</sup>
</td><td>32.8</td><td>&#x000b1;</td><td>0.2</td></tr><tr><td>(%)</td><td>LE</td><td>32.8</td><td>&#x000b1;</td><td>0.2</td><td>32.7</td><td>&#x000b1;</td><td>0.2</td><td>32.7</td><td>&#x000b1;</td><td>0.1</td></tr><tr><td>Platelet</td><td>Control</td><td>23.8</td><td>&#x000b1;</td><td>1.4</td><td>23.0</td><td>&#x000b1;</td><td>0.9</td><td>22.7</td><td>&#x000b1;</td><td>0.9</td></tr><tr><td>(/&#x003bc;L)</td><td>LE</td><td>23.7</td><td>&#x000b1;</td><td>1.3</td><td>22.5</td><td>&#x000b1;</td><td>1.2</td><td>22.7</td><td>&#x000b1;</td><td>1.2</td></tr><tr><td>AST</td><td>Control</td><td>21.9</td><td>&#x000b1;</td><td>1.8</td><td>22.1</td><td>&#x000b1;</td><td>2.0</td><td>24.4</td><td>&#x000b1;</td><td>3.8</td></tr><tr><td>(IU/L)</td><td>LE</td><td>22.1</td><td>&#x000b1;</td><td>1.3</td><td>24.7</td><td>&#x000b1;</td><td>1.9</td><td>24.9</td><td>&#x000b1;</td><td>2.3</td></tr><tr><td>ALT</td><td>Control</td><td>27.9</td><td>&#x000b1;</td><td>4.2</td><td>27.2</td><td>&#x000b1;</td><td>4.2</td><td>30.8</td><td>&#x000b1;</td><td>7.1</td></tr><tr><td>(IU/L)</td><td>LE</td><td>25.0</td><td>&#x000b1;</td><td>2.1</td><td>39.8</td><td>&#x000b1;</td><td>3.2</td><td>28.0</td><td>&#x000b1;</td><td>2.5</td></tr><tr><td>&#x003b3;-GTP</td><td>Control</td><td>49.2</td><td>&#x000b1;</td><td>12.2</td><td>48.0</td><td>&#x000b1;</td><td>11.1</td><td>42.4</td><td>&#x000b1;</td><td>9.1</td></tr><tr><td>(IU/L)</td><td>LE</td><td>42.7</td><td>&#x000b1;</td><td>9.2</td><td>44.3</td><td>&#x000b1;</td><td>8.9</td><td>40.6</td><td>&#x000b1;</td><td>7.3</td></tr><tr><td>BUN</td><td>Control</td><td>14.6</td><td>&#x000b1;</td><td>0.9</td><td>15.6</td><td>&#x000b1;</td><td>0.7</td><td>14.5</td><td>&#x000b1;</td><td>0.7</td></tr><tr><td>(mg/dL)</td><td>LE</td><td>13.8</td><td>&#x000b1;</td><td>0.9</td><td>15.9</td><td>&#x000b1;</td><td>0.8<sup>a</sup>
</td><td>15.2</td><td>&#x000b1;</td><td>0.7</td></tr><tr><td>Cr</td><td>Control</td><td>0.737</td><td>&#x000b1;</td><td>0.024</td><td>0.758</td><td>&#x000b1;</td><td>0.025</td><td>0.736</td><td>&#x000b1;</td><td>0.027</td></tr><tr><td>(mg/dL)</td><td>LE</td><td>0.839</td><td>&#x000b1;</td><td>0.032#</td><td>0.849</td><td>&#x000b1;</td><td>0.030#</td><td>0.853</td><td>&#x000b1;</td><td>0.035#</td></tr><tr><td>UA</td><td>Control</td><td>6.23</td><td>&#x000b1;</td><td>0.28</td><td>6.56</td><td>&#x000b1;</td><td>0.28</td><td>6.17</td><td>&#x000b1;</td><td>0.30</td></tr><tr><td>(mg/dL)</td><td>LE</td><td>6.32</td><td>&#x000b1;</td><td>0.24</td><td>6.49</td><td>&#x000b1;</td><td>0.23</td><td>6.18</td><td>&#x000b1;</td><td>0.24</td></tr></tbody></table><table-wrap-foot><p>Mean&#x02009;&#x000b1;&#x02009;SE of 18 (control) and 19 (LE)</p><p>
<sup>a</sup>p&#x02009;&#x0003c;&#x02009;0.05 vs. 0&#x000a0;weeks by Dunnett test&#x03001;#p&#x02009;&#x0003c;&#x02009;0.05 vs. Control by Student&#x02019;s <italic>t</italic>-test</p><p>
<italic>Control</italic> Control group, <italic>LE</italic> Lactic fermented egg white group</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec15"><title>Liver and kidney functions indices</title><p id="Par32">While the LE group exhibited significantly higher BUN levels in week 6 compared to baseline (p&#x02009;&#x0003c;&#x02009;0.05), BUN was within the normal range, with no significant difference observed in week 12. The LE group showed significantly lower creatinine levels than the control group at baseline and in week 12 (p&#x02009;&#x0003c;&#x02009;0.05). However, there was no significant variation observed throughout the intake period, and because changes were within the normal range, this was not considered to pose any problem. For all other items, no influence of the test foods was observed (Table <xref rid="Tab5" ref-type="table">5</xref>).</p></sec></sec><sec id="Sec16"><title>Discussion</title><p id="Par33">Results of this study indicated that when 8&#x000a0;g of LE (i.e., EWP) was consumed daily for 12&#x000a0;weeks, VFA was significantly reduced compared to baseline and the control group. Therefore, we concluded that LE has a visceral fat-reduction effect. It has been previously reported that the visceral fat-reduction food constituents include catechine [<xref ref-type="bibr" rid="CR19">19</xref>] and polyphenol [<xref ref-type="bibr" rid="CR20">20</xref>]. The degree by which these constituents reduced visceral fat of the food consumed for 12&#x000a0;weeks was &#x02212;10.3&#x000a0;cm<sup>2</sup> for catechine and &#x02212;7.9&#x000a0;cm<sup>2</sup> for polyphenol, compared to a reduction of 8.89&#x000a0;cm<sup>2</sup> by LE in this study. This finding suggests that LE has the same effect as food constituents that are generally considered to reduce visceral fat. It has been reported that protein-derived constituents also reduce visceral fat, and therefore, in this study we evaluated the effect of a daily intake of 8&#x000a0;g of lactic acid-fermented albumin as protein, based on a report on beta-conglycinin in soybeans [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. However, this study did not examine whether less than 8&#x000a0;g of EWP would exhibit a visceral fat-reduction effect and this requires further study. Furthermore, it has been reported that lactoferrin (LF), found in milk protein, has a visceral fat-reduction effect [<xref ref-type="bibr" rid="CR21">21</xref>]. It has been found that a daily intake of 300&#x000a0;mg of LF significantly reduced VFA compared to baseline and the control group. In this study, the control group was given whey, which contains LF. It was expected that a daily intake of 8&#x000a0;g of whey would correspond to a daily intake of 450&#x000a0;mg of LF and was therefore expected to have a visceral fat-reduction effect. However, whey did not reduce visceral fat in the control group. A possible explanation is that whey contains many nutrients other than LF, which may have competed. It has previously been reported that a daily intake of 28&#x000a0;g of whey had no effect on visceral fat [<xref ref-type="bibr" rid="CR22">22</xref>]. It was reported that it needs to be subjected to enteric coating to exert its visceral fat&#x02013;reducing effects because LF itself is vulnerable to heating and is easily degraded by gastric acid [<xref ref-type="bibr" rid="CR21">21</xref>]. This should explain why the whey sample used in the present study failed to reduce visceral fat.</p><p id="Par34">Furthermore, in this study the ratio of visceral to subcutaneous fat was significantly reduced after consumption of LE compared to baseline ratio and the control group. The visceral to subcutaneous fat ratio is an indicator of visceral fat obesity, with a ratio&#x02009;&#x0003e;&#x02009;0.4 indicating visceral fat obesity [<xref ref-type="bibr" rid="CR23">23</xref>]. In our study, LE not only reduced VFA but also considerably reduced the visceral to subcutaneous fat ratio; therefore, we concluded that the symptoms of visceral fat obesity had reduced.</p><p id="Par35">Although it is unclear why LE intake reduces visceral fat, it has been reported that EWP, the main constituent of LE, has an inhibitory effect on the absorption of triglycerides [<xref ref-type="bibr" rid="CR11">11</xref>]. EWP inhibited the absorption of fat, thereby functioning to reduce lipid content within bile acid micelles. The components involved in this process are ovalbumin and ovotransferrin, both of which reduce lipid content within bile acid micelles to an equivalent extent. No other components have been shown to affect this process [<xref ref-type="bibr" rid="CR11">11</xref>]. As such, we inferred that these two components might also have come into play in this experiment. Especially, the underlying cause of this has been reported to involve lipase inhibitory activity in ovalbumin [<xref ref-type="bibr" rid="CR24">24</xref>], the main constituent of EWP, as well as the inhibitory effect of lipid micelles [<xref ref-type="bibr" rid="CR11">11</xref>]. Furthermore, ovalbumin has been found to form FFAs and gels [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. Therefore, it is believed that EWP can inhibit the absorption of lipids by way of its physicochemical properties.</p><p id="Par36">EWP has an amino acid score of 100, with a higher rate of net protein utilization than soy and milk proteins [<xref ref-type="bibr" rid="CR27">27</xref>]. In a previous examination of the effect of EWP on carcass protein contents in rat compared to casein, we reported that EWP showed significantly higher levels than casein [<xref ref-type="bibr" rid="CR12">12</xref>]. As the main constituent of muscle is protein, it is believed that the increase in carcass protein contents in rats were due to increased muscle mass. In general, however, a muscle does not increase without exercise; thus, further studies should be conducted to determine whether a muscle increases because of the high net protein utilization and increased body protein. The fact that muscle burns fat in the event of increased muscle may be one explanation for the observed reduction in visceral fat.</p><p id="Par37">It is generally believed that active food constituents that reduce visceral fat are often those whose structures do not change through absorption or metabolic process (e.g., polyphenol), the effects of which are easily evaluated in vivo. In contrast, proteins become effective after being broken down into peptides and amino acids in the digestive tract. With regards to the details of the active constituents contained in EWP, we believe that the visceral fat-reduction mechanism should first be clarified and then confirmed via in vitro evaluation.</p><p id="Par38">In this study, participants consumed either LE or whey drink at breakfast. Suzuki et al. reported that pre-exercise intake of EWP increases muscle and muscular strength [<xref ref-type="bibr" rid="CR28">28</xref>]. It has been reported that consuming hen&#x02019;s eggs at breakfast induced satiety and reduced participants&#x02019; body fat [<xref ref-type="bibr" rid="CR29">29</xref>]. However, in this study, while participants&#x02019; energy intake hardly changed and the lactic acid drink did not affect their satiety, we confirmed that visceral fat was reduced. On the contrary, protein intake following muscle strength training is recommended to increase muscles [<xref ref-type="bibr" rid="CR30">30</xref>]. Therefore, we believe that consuming LE after dinner or before sleeping might reduce visceral fat more effectively. Furthermore, if the visceral fat-reduction mechanism of EWP lies in the inhibition of lipid absorption [<xref ref-type="bibr" rid="CR11">11</xref>], it may be preferable to consume LE at dinnertime, the meal with the highest energy intake. Moreover, previous research has reported that the circadian rhythm gene BMAL1, which is involved in lipid accumulation [<xref ref-type="bibr" rid="CR31">31</xref>], is abundantly secreted at night. Therefore, we believe that the consumption of LE at dinnertime could more effectively inhibit the accumulation of lipids. Per these factors, while the present study indicated that LE intake at breakfast reduces VFA, the timing at which it effectively reduces visceral fat was not clarified and should be examined in future studies.</p><p id="Par39">In the present study, the blood biomarkers exhibited no significant differences between week 0, week 6, and week 12. Although the present study involved subjects with slightly high levels of visceral fat weight, the other parameters such as blood lipids were within the normal range. This might have resulted in no significant changes being observed in the blood biomarkers. In previous studies, subjects with slightly high levels of serum cholesterol showed significant decreases in serum total cholesterol and LDL-cholesterol concentrations at week 4 and week 8 during 8&#x000a0;weeks of LE consumption as compared with prior to consumption [<xref ref-type="bibr" rid="CR8">8</xref>]. This suggests the possibility that marked improvements may be achieved if subjects with borderline or abnormal blood biomarker values are involved.</p><p id="Par40">Concern has been raised that EWP intake could cause allergies and biotin deficiency. In this study, individuals with food allergies were excluded during recruitment. It has been demonstrated that avidin found in raw egg whites binds to biotin, thereby reducing its absorption [<xref ref-type="bibr" rid="CR32">32</xref>]. While the participants of this study were asked to consume 8&#x000a0;g of EWP per day for 12 consecutive weeks, there was no sign of clinical symptoms. A study in which participants consumed 200&#x000a0;g of dried egg white (approximately 160&#x000a0;g of EWP) daily reported signs of biotin deficiency after week 7 [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. The consumption period was 12&#x000a0;weeks; however, the amount of EWP intake was 8&#x000a0;g, which was 1/20th of the amount of EWP that caused biotin deficiency in the previous study, and may explain the observed lack of biotin deficiency. Furthermore, when egg white is in its raw state or heated, it has been reported that electrophoretic avidine bands disappear upon activation of pepsin [<xref ref-type="bibr" rid="CR34">34</xref>]. During the digestive process, as pepsin is usually activated, we believe that a daily intake of 8&#x000a0;g of LE for 12&#x000a0;weeks should not cause biotin deficiency. Finally, we measured markers of liver and kidney function. No abnormal increases or decreases in numeric values were observed, suggesting that EWP can be consumed safely.</p><p id="Par41">Metabolic syndrome, triggered by obesity, leads to hypertension, abnormal glucose tolerance, and is ultimately considered a cause of arteriosclerotic diseases. If we pursue this study further and clarify the visceral fat-reduction effect of EWP, we believe that it could improve the quality of life of patients with obesity. Furthermore, if the practical application of LE, which facilitates the egg white intake, becomes available, we believe that it would provide a good source of protein while reducing visceral fat and might be utilized to promote the health among the Japanese.</p></sec><sec id="Sec17"><title>Conclusions</title><p id="Par42">The results demonstrated that LE reduces VFA and improves the ratio of visceral to subcutaneous fat area. As other measurement items were not influenced, we concluded that LE improves visceral fat obesity.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>BMI</term><def><p id="Par6">Body Mass Index</p></def></def-item><def-item><term>CT</term><def><p id="Par7">Computed tomographic</p></def></def-item><def-item><term>EWP</term><def><p id="Par8">Egg white protein</p></def></def-item><def-item><term>LE</term><def><p id="Par9">Lactic-fermented egg white</p></def></def-item><def-item><term>VFA</term><def><p id="Par10">Visceral fat area</p></def></def-item></def-list></glossary><ack><p>This study was supported completely by a grant received from Kewpie Corporation, Japan. We thank Prof. Michihiro Sugano (Kyushu University, and Prefectural University of Kumamoto) for providing technical advice about this trial. The authors would like to thank Enago (<ext-link ext-link-type="uri" xlink:href="http://www.enago.jp">www.enago.jp</ext-link>) for the English language review.</p><sec id="FPar1"><title>Funding</title><p id="Par43">Experimental work in Nutrition Clinic, Kagawa Nutrition University was supported by Kewpie Corporation (Tokyo, Japan).</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p id="Par44">The dataset supporting the conclusions of this article is included within the article.</p></sec></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>RM, KK, MU, WW, YM, MK, AT, and KU conceived the study concept and design. AT, as the principal investigator, was responsible for study logistics, data acquisition and RM and KK for manuscript preparation. KK, MU, and WW were responsible for conducting the trial, data collection, and performing laboratory analysis. RM and AT carried out the statistical analysis. YM, MK, and KU supervised the study design and commented on the manuscript. All authors contributed to the intellectual content of the manuscript. All authors read and approved the final amnuscript.</p></notes><notes notes-type="COI-statement"><sec id="FPar3"><title>Ethics approval and consent to participate</title><p id="Par45">This study was conducted in accordance with the Declaration of Helsinki, and with the approval of the Ethics Committee of Kagawa Education Institute of Nutrition (authorization no. 243; 13th March, 2013). Participants received a thorough explanation of the study protocol and those who provided consent were included. The study was conducted at the Nutritional Clinic of Kagawa Education Institute of Nutrition.</p></sec><sec id="FPar4"><title>Consent for publication</title><p id="Par46">Not applicable.</p></sec><sec id="FPar5"><title>Competing interests</title><p id="Par47">KK, AT, KU declare no conflict of interest. RM, MU, WW, Y.M. and M.K. are employees of Kewpie Corporation. There are no other patents, products in development or marketed products to declare.</p></sec><sec id="FPar6"><title>Publisher&#x02019;s Note</title><p id="Par48">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alberti</surname><given-names>KG</given-names></name><name><surname>Zimmet</surname><given-names>PZ</given-names></name></person-group><article-title>Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation</article-title><source>Diabet Med</source><year>1998</year><volume>15</volume><fpage>539</fpage><lpage>553</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-9136(199807)15:7&#x0003c;539::AID-DIA668&#x0003e;3.0.CO;2-S</pub-id><pub-id pub-id-type="pmid">9686693</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>Y</given-names></name><name><surname>Hamasaki</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>S</given-names></name><name><surname>Ando</surname><given-names>Y</given-names></name></person-group><article-title>Relationship between the attitudes towards improving eating habits and prevalence of metabolic syndrome. Data from the 2005 National Health and nutrition survey and the comprehensive survey of living conditions</article-title><source>Nihon Koshu Eisei Zasshi</source><year>2014</year><volume>61</volume><fpage>385</fpage><lpage>395</lpage><pub-id pub-id-type="pmid">25297977</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruxto</surname><given-names>C</given-names></name></person-group><article-title>Recommendation for the use of egg in the diet</article-title><source>Nurs Stand</source><year>2010</year><volume>24</volume><fpage>47</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.7748/ns.24.37.47.s53</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kats</surname><given-names>DL</given-names></name><name><surname>Evans</surname><given-names>MA</given-names></name><name><surname>Namaz</surname><given-names>H</given-names></name><name><surname>Hjike</surname><given-names>VY</given-names></name><name><surname>Chan</surname><given-names>W</given-names></name><name><surname>Comerford</surname><given-names>BP</given-names></name><name><surname>Hoxley</surname><given-names>ML</given-names></name></person-group><article-title>Egg consumption and endothelial function: a randomized controlled crossover trial</article-title><source>Int J Cardiol</source><year>2010</year><volume>99</volume><fpage>65</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2003.11.028</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Njike</surname><given-names>V</given-names></name><name><surname>Faridi</surname><given-names>Z</given-names></name><name><surname>Dutta</surname><given-names>S</given-names></name><name><surname>Gonzalez-Simon</surname><given-names>AL</given-names></name><name><surname>Kalz</surname><given-names>DL</given-names></name></person-group><article-title>Dietary egg consumption in hyperlipidemic adults-effects on endothelial function and cardiovascular risk</article-title><source>Nutr J</source><year>2010</year><volume>9</volume><fpage>28</fpage><pub-id pub-id-type="doi">10.1186/1475-2891-9-28</pub-id><pub-id pub-id-type="pmid">20598142</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Iso</surname><given-names>H</given-names></name><name><surname>Kita</surname><given-names>Y</given-names></name><name><surname>Ueshima</surname><given-names>H</given-names></name><name><surname>Okada</surname><given-names>K</given-names></name><name><surname>Konishi</surname><given-names>M</given-names></name><name><surname>Inoue</surname><given-names>M</given-names></name><name><surname>Tsugane</surname><given-names>S</given-names></name></person-group><article-title>Egg consumption serum total cholesterol concentrations and coronary heart disease incidence: Japanese public health center-based prospective study</article-title><source>Br J Nutr</source><year>2006</year><volume>96</volume><fpage>921</fpage><lpage>928</lpage><pub-id pub-id-type="doi">10.1017/BJN20061937</pub-id><pub-id pub-id-type="pmid">17092383</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNamara</surname><given-names>DJ</given-names></name></person-group><article-title>Dietary cholesterol and atherosclerosis</article-title><source>Biochem Biophys Acta</source><year>2000</year><volume>1529</volume><fpage>310</fpage><lpage>320</lpage><pub-id pub-id-type="pmid">11111098</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asato</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>MF</given-names></name><name><surname>Chan</surname><given-names>YC</given-names></name><name><surname>Yeh</surname><given-names>SH</given-names></name><name><surname>Chung</surname><given-names>HM</given-names></name><name><surname>Chung</surname><given-names>SY</given-names></name><name><surname>Chida</surname><given-names>S</given-names></name><name><surname>Uezato</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>I</given-names></name><name><surname>Yamagata</surname><given-names>N</given-names></name><name><surname>Kokubu</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>S</given-names></name></person-group><article-title>Effect of egg white on serum cholesterol concentration in young women</article-title><source>J Nutr Sci Vitaminol.</source><year>1996</year><volume>42</volume><fpage>87</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.3177/jnsv.42.87</pub-id><pub-id pub-id-type="pmid">8780967</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuoka</surname><given-names>R</given-names></name><name><surname>Kimura</surname><given-names>M</given-names></name><name><surname>Muto</surname><given-names>A</given-names></name><name><surname>Masuda</surname><given-names>Y</given-names></name><name><surname>Sato</surname><given-names>M</given-names></name><name><surname>Imaizumi</surname><given-names>K</given-names></name></person-group><article-title>Mechanism for the cholesterol-lowering action of egg white protein in rats</article-title><source>Biosci Biotechnol Biochem</source><year>2008</year><volume>72</volume><fpage>1506</fpage><lpage>1512</lpage><pub-id pub-id-type="doi">10.1271/bbb.80016</pub-id><pub-id pub-id-type="pmid">18540106</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="other">Matsuoka R, Takahashi Y, Kimura M, Masuda Y, Kunou M. Heating has no effect on the net protein utilisation from egg whites in rats. Sci World J. 2017:6817196.</mixed-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuoka</surname><given-names>R</given-names></name><name><surname>Shirouchi</surname><given-names>B</given-names></name><name><surname>Kawamura</surname><given-names>S</given-names></name><name><surname>Baba</surname><given-names>S</given-names></name><name><surname>Shiratake</surname><given-names>S</given-names></name><name><surname>Nagata</surname><given-names>K</given-names></name><name><surname>Imaizumi</surname><given-names>K</given-names></name><name><surname>Sato</surname><given-names>M</given-names></name></person-group><article-title>Dietary egg white protein inhibits lymphatic lipid transport in thoracic lymph duct-cannulated rats</article-title><source>J Agr Food Chem</source><year>2014</year><volume>62</volume><fpage>10694</fpage><lpage>10700</lpage><pub-id pub-id-type="doi">10.1021/jf502741b</pub-id><pub-id pub-id-type="pmid">25300535</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuoka</surname><given-names>R</given-names></name><name><surname>Shirouchi</surname><given-names>B</given-names></name><name><surname>Umegatani</surname><given-names>M</given-names></name><name><surname>Fukuda</surname><given-names>M</given-names></name><name><surname>Muto</surname><given-names>A</given-names></name><name><surname>Masuda</surname><given-names>Y</given-names></name><name><surname>Kunou</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>M</given-names></name></person-group><article-title>Dietary egg-white protein increased body protein mass and reduces body fat mass through an acceleration of hepatic &#x003b2;-oxidation in rats</article-title><source>Br J Nutr</source><year>2017</year><volume>118</volume><fpage>423</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1017/S0007114517002306</pub-id><pub-id pub-id-type="pmid">28980893</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arimitsu</surname><given-names>K</given-names></name><name><surname>Takashi</surname><given-names>K</given-names></name><name><surname>Matsuoka</surname><given-names>R</given-names></name><name><surname>Narita</surname><given-names>K</given-names></name><name><surname>Idei</surname><given-names>A</given-names></name></person-group><article-title>The good function of lactic fermented egg white &#x0201c;Lacty Egg.&#x0201d;</article-title><source>Jpn J Food Engineering</source><year>2015</year><volume>16</volume><fpage>79</fpage><lpage>82</lpage></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuoka</surname><given-names>R</given-names></name><name><surname>Usuda</surname><given-names>M</given-names></name><name><surname>Masuda</surname><given-names>Y</given-names></name><name><surname>Kunou</surname><given-names>M</given-names></name><name><surname>Utsunomiya</surname><given-names>K</given-names></name></person-group><article-title>Lactic-fermented egg white reduced serum cholesterol concentrations in mildly Hypercholesterolemic Japanese men: a double-blind, parallel-arm design</article-title><source>Lipids Health Dis</source><year>2017</year><volume>16</volume><fpage>101</fpage><pub-id pub-id-type="doi">10.1186/s12944-017-0499-1</pub-id><pub-id pub-id-type="pmid">28558718</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohno</surname><given-names>M</given-names></name><name><surname>Hirotsuka</surname><given-names>M</given-names></name><name><surname>Kito</surname><given-names>M</given-names></name><name><surname>Matsuzawa</surname><given-names>Y</given-names></name></person-group><article-title>Decreases in serum triglycerol and visceral fat mediated by dietary soybean beta-conglycinin</article-title><source>J Atheroscler Thromb</source><year>2006</year><volume>13</volume><fpage>247</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.5551/jat.13.247</pub-id><pub-id pub-id-type="pmid">17146153</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>R</given-names></name><name><surname>Takeyama</surname><given-names>M</given-names></name><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Umemura</surname><given-names>O</given-names></name></person-group><article-title>Constituent proteins of globulin fraction obtained from egg white</article-title><source>Agric Biol Chem</source><year>1980</year><volume>44</volume><fpage>2357</fpage><lpage>2362</lpage></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimberly</surname><given-names>AE</given-names></name><name><surname>Roberts</surname><given-names>MGA</given-names></name></person-group><article-title>Method for the direct determination of organic nitrogen by the Kjeldahl process</article-title><source>Public Health Pap Rep</source><year>1905</year><volume>31</volume><fpage>109</fpage><lpage>122</lpage><pub-id pub-id-type="pmid">19601246</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedewald</surname><given-names>WT</given-names></name><name><surname>Levy</surname><given-names>RI</given-names></name><name><surname>Frederickson</surname><given-names>DS</given-names></name></person-group><article-title>Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge</article-title><source>Clin Chem</source><year>1972</year><volume>18</volume><fpage>499</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">4337382</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagao</surname><given-names>T</given-names></name><name><surname>Hase</surname><given-names>T</given-names></name><name><surname>Tokimitsu</surname><given-names>IA</given-names></name></person-group><article-title>Green tea extract high in cathechins reduces body fat and cardiovascular risks in humans</article-title><source>Obesity</source><year>2007</year><volume>15</volume><fpage>1473</fpage><lpage>1483</lpage><pub-id pub-id-type="doi">10.1038/oby.2007.176</pub-id><pub-id pub-id-type="pmid">17557985</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akazome</surname><given-names>Y</given-names></name><name><surname>Kametani</surname><given-names>N</given-names></name><name><surname>Kanda</surname><given-names>T</given-names></name><name><surname>Shimasaki</surname><given-names>H</given-names></name><name><surname>Kobayashi</surname><given-names>S</given-names></name></person-group><article-title>Evaluation of safety of excessive intake and efficacy of long-term intake of beverages containing apple polyphenols</article-title><source>J Oleo Sci</source><year>2010</year><volume>59</volume><fpage>321</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.5650/jos.59.321</pub-id><pub-id pub-id-type="pmid">20484838</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ono</surname><given-names>T</given-names></name><name><surname>Murakoshi</surname><given-names>M</given-names></name><name><surname>Suzuki</surname><given-names>N</given-names></name><name><surname>Iida</surname><given-names>N</given-names></name><name><surname>Ohdera</surname><given-names>M</given-names></name><name><surname>Iigo</surname><given-names>M</given-names></name><name><surname>Yoshida</surname><given-names>T</given-names></name><name><surname>Sugiyama</surname><given-names>K</given-names></name><name><surname>Nishino</surname><given-names>H</given-names></name></person-group><article-title>Potent anti-obesity effect of enreric-coated lactoferrin: decrease in visceral fat accumulation in Japanese men and women with abdominal obesity after 8-week administration of enteric coated lactofferin tablets</article-title><source>Br J Nutr</source><year>2010</year><volume>104</volume><fpage>1688</fpage><lpage>1695</lpage><pub-id pub-id-type="doi">10.1017/S0007114510002734</pub-id><pub-id pub-id-type="pmid">20691130</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beer</surname><given-names>DJ</given-names></name><name><surname>Stoke</surname><given-names>KS</given-names></name><name><surname>Paul</surname><given-names>DR</given-names></name><name><surname>Harris</surname><given-names>GK</given-names></name><name><surname>Rumpler</surname><given-names>WV</given-names></name><name><surname>Clevidence</surname><given-names>BA</given-names></name></person-group><article-title>Whey protein but not soy protein supplementation alters body weight and composition in free-living overweight and obese adults</article-title><source>J Nutr</source><year>2011</year><volume>141</volume><fpage>1489</fpage><lpage>1494</lpage><pub-id pub-id-type="doi">10.3945/jn.111.139840</pub-id><pub-id pub-id-type="pmid">21677076</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadowaki</surname><given-names>T</given-names></name><name><surname>Sekikawa</surname><given-names>A</given-names></name><name><surname>Murata</surname><given-names>K</given-names></name><name><surname>Maegawa</surname><given-names>H</given-names></name><name><surname>Takamiya</surname><given-names>T</given-names></name><name><surname>Okamura</surname><given-names>T</given-names></name><name><surname>El-Saed</surname><given-names>A</given-names></name><name><surname>Miyamatsu</surname><given-names>N</given-names></name><name><surname>Edmundowicz</surname><given-names>D</given-names></name><name><surname>Kita</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Japanese men have larger areas of visceral adipose tissue than Caucasian men in the same levels of waist circumference in a population-based study</article-title><source>IntJ Obesity</source><year>2006</year><volume>30</volume><fpage>1163</fpage><lpage>1165</lpage><pub-id pub-id-type="doi">10.1038/sj.ijo.0803248</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gargouri</surname><given-names>Y</given-names></name><name><surname>Julien</surname><given-names>R</given-names></name><name><surname>Sugihara</surname><given-names>A</given-names></name><name><surname>Verger</surname><given-names>R</given-names></name><name><surname>Sarda</surname><given-names>L</given-names></name></person-group><article-title>Inhibition of pancreatic and microbial lipases by proteins</article-title><source>Biochim Biophys Acta</source><year>1984</year><volume>795</volume><fpage>326</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1016/0005-2760(84)90082-1</pub-id><pub-id pub-id-type="pmid">6477949</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uno-Ohta</surname><given-names>N</given-names></name><name><surname>Toryu</surname><given-names>H</given-names></name><name><surname>Higasa</surname><given-names>T</given-names></name><name><surname>Maeda</surname><given-names>H</given-names></name><name><surname>Okada</surname><given-names>M</given-names></name><name><surname>Ohta</surname><given-names>H</given-names></name></person-group><article-title>Gelation properties of ovalbumin as affected by fatty acid salts</article-title><source>J Food Sci</source><year>1996</year><volume>61</volume><fpage>906</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2621.1996.tb10899.x</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Handa</surname><given-names>A</given-names></name><name><surname>Gebbadios</surname><given-names>A</given-names></name><name><surname>Hanna</surname><given-names>MA</given-names></name><name><surname>Weller</surname><given-names>CL</given-names></name><name><surname>Kuroda</surname><given-names>N</given-names></name></person-group><article-title>Physical and molecular properties of egg-white lipid films</article-title><source>Food Chem Toxicol</source><year>1999</year><volume>64</volume><fpage>860</fpage><lpage>864</lpage></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheffner</surname><given-names>AL</given-names></name><name><surname>Eckfeldt</surname><given-names>GA</given-names></name><name><surname>Spector</surname><given-names>H</given-names></name></person-group><article-title>The pepsin-digest-residue (PDR) amino acid index of net protein utilization</article-title><source>J Nutr</source><year>1956</year><volume>60</volume><fpage>105</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">13367898</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>Y</given-names></name><name><surname>Sawada</surname><given-names>A</given-names></name><name><surname>Numao</surname><given-names>S</given-names></name><name><surname>Suzuki</surname><given-names>M</given-names></name></person-group><article-title>Chronic effect of light resistance exercise after ingestion of a high protein snack on increase of skeletal muscle mass and strength in young adults</article-title><source>J Nutr Sci Vitaminol</source><year>2011</year><volume>57</volume><fpage>233</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.3177/jnsv.57.233</pub-id><pub-id pub-id-type="pmid">21908946</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fallaize</surname><given-names>R</given-names></name><name><surname>Wilson</surname><given-names>L</given-names></name><name><surname>Gray</surname><given-names>J</given-names></name><name><surname>Morgan</surname><given-names>LM</given-names></name><name><surname>Griffin</surname><given-names>BA</given-names></name></person-group><article-title>Variation in the effects of three different breakfast meals on subjective satiety and subsequent intake of energy at lunch and evening meal</article-title><source>Eur J Nutr</source><year>2013</year><volume>52</volume><fpage>1353</fpage><lpage>1359</lpage><pub-id pub-id-type="doi">10.1007/s00394-012-0444-z</pub-id><pub-id pub-id-type="pmid">22948783</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>SB</given-names></name><name><surname>Tarnopolsky</surname><given-names>MA</given-names></name><name><surname>Macdonald</surname><given-names>MJ</given-names></name><name><surname>Macdonald</surname><given-names>JR</given-names></name><name><surname>Armstrong</surname><given-names>D</given-names></name><name><surname>Phillips</surname><given-names>SM</given-names></name></person-group><article-title>Consumption of fluid skim milk promotes greater muscle protein accretion after resistance exercise than does consumption of an isonitrogenous and isoenergetic soy-protein beverage</article-title><source>Am J Clin Nutr</source><year>2007</year><volume>85</volume><fpage>1031</fpage><lpage>1340</lpage><pub-id pub-id-type="pmid">17413102</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimba</surname><given-names>S</given-names></name></person-group><article-title>The roles of clock genes in obesity</article-title><source>Nihon Rinsho</source><year>2013</year><volume>71</volume><fpage>244</fpage><lpage>248</lpage><pub-id pub-id-type="pmid">23631200</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Said</surname><given-names>AM</given-names></name></person-group><article-title>Cell and molecular aspect of human intestinal biotin absorption</article-title><source>J Nutr</source><year>2008</year><volume>139</volume><fpage>158</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.3945/jn.108.092023</pub-id><pub-id pub-id-type="pmid">19056639</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baugh</surname><given-names>CM</given-names></name><name><surname>Malone</surname><given-names>JH</given-names></name></person-group><article-title>Human biotin deficiency, a case history of biotin deficiency induced by raw egg consumption in a cirriphotic patient</article-title><source>Am J Clin Nutr</source><year>1968</year><volume>21</volume><fpage>173</fpage><lpage>182</lpage><pub-id pub-id-type="pmid">5642891</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakai</surname><given-names>K</given-names></name><name><surname>Ushiyama</surname><given-names>Y</given-names></name><name><surname>Manabe</surname><given-names>S</given-names></name></person-group><article-title>Peptic and pancreatic digestibility of raw and heat-coagulated hen&#x02019;s egg white proteins</article-title><source>Jpn J Pediatr Allergy Clin Immunol</source><year>1999</year><volume>13</volume><fpage>36</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.3388/jspaci.13.36</pub-id></element-citation></ref></ref-list></back></article>